Aminoguanidine prevents concanavalin A-induced hepatitis in mice

By Okamoto T.   Masuda Y.   Kawasaki T.   Shinohara M.   Matsuzaki K.  

European Journal of Pharmacology, Vol. 396, Iss. 2, 2000-05 ,pp. : 125-130

Elsevier

Access to resources Recommend Favorite

Prevention by rolipram of concanavalin A-induced T-cell-dependent hepatitis in mice

By Xiang M.   Zaccone P.   Di Marco R.   Magro G.   Di Mauro M.   Beltrami B.   Meroni P.   Nicoletti F.  

European Journal of Pharmacology, Vol. 367, Iss. 2, 1999-02 ,pp. : 399-404

Elsevier

Access to resources Recommend Favorite

Mechanisms of ketamine-involved regulation of cytochrome P450 gene expression

By Chen Jui-Tai   Chen Ruei-Ming  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 3, 2010-03 ,pp. : 273-281

Informa Healthcare

Access to resources Recommend Favorite

Protective effects of soyasapogenol A on liver injury mediated by immune response in a concanavalin A-induced hepatitis model

By Kuzuhara H.   Nishiyama S.   Minowa N.   Sasaki K.   Omoto S.  

European Journal of Pharmacology, Vol. 391, Iss. 1, 2000-03 ,pp. : 175-181

Elsevier

Access to resources Recommend Favorite

Impaired NK cell cytotoxicity by high level of interferon-γ in concanavalin A-induced hepatitis

By Dong Zhongjun   Zhang Cai   Wei Haiming   Sun Rui   Tian Zhigang  

Canadian Journal of Physiology and Pharmacology, Vol. 83, Iss. 11, 2005-11 ,pp. : 1045-1053

NRC Research Press

Access to resources Recommend Favorite